Germany And The U.S Fight Over COVID-19 Vaccine As The U.S Wants To Keep The Vaccine For Itself

As reported by Welt am Sonntag, a German newspaper, the government of Germany and the U.S are fighting over CureVac, a German company, which is reportedly working on the vaccine for COVID-19.

The report said that U.S president Donald Trump has offered the German scientists a large sum of money to get the exclusive right to the vaccine after it is created.

However, CureVac said on Sunday that it had no intention to sell its own or its technology.

The paper quoted a German government official as saying that Donald Trump wanted the vaccine for the U.S and the U.S alone.

On Sunday, CureVac’s biggest investor said that the company would make a vaccine for the whole world, not some individual nations.

According to Jens Spahn, German Health Minister, takeover was out of the question and the German government was in good talks with CureVac in the last two weeks.

CureVac is based in Tübingen, a city in Southern Germany, and it is in collaboration with the Paul Ehrlich Institute. The company also has branches in Frankfurt and Boston. The company said that it hoped to have an experimental vaccine by July and is cleared for human trials by the that time.

The COVID-19 outbreak started in China and has spread globally with a total number of cases of 156,000 and 5,800 died if the illness. Around 70,000 people have recovered, proving that on some people, the Coronavirus can cause only mild symptoms but can take the lives of many others.

On the 2^nd of March, Daniel Menichella, former CEO of CureVac attended a meeting with the U.S president Donald Trump at the White House to talk about vaccine development.

However, on March 11, the company announced that Ingmar Hoerr, one of its founders, would take over the CEO position without saying why.

>>> Indian-Born Scientist Joins Researching Team To Find A Cure For COVID-19